Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $7.2650 (2.18%) ($7.2650 - $7.2900) on Thu. Aug. 24, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.16% (three month average) | RSI | 44 | Latest Price | $7.2650(2.18%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX advances 0.8% a day on average for past five trading days. | Weekly Trend | BCRX advances 1.3% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) UNG(50%) XOP(34%) SMH(32%) USO(31%) XLE(28%) | Factors Impacting BCRX price | BCRX will decline at least -1.58% in a week (0% probabilities). XLRE(-37%) ARKK(-31%) PCY(-30%) XLP(-27%) XLY(-22%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -1.58% (StdDev 3.16%) | Hourly BBV | 0.5 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $7.24(0.35%) | 10 Day Moving Average | $7.12(2.04%) | 20 Day Moving Average | $7.13(1.89%) | To recent high | -18% | To recent low | 8.4% | Market Cap | $1.282b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |